Where it matters
Grassroots Sport
Community and amateur sport represents an important opportunity to improve concussion assessment, particularly where access to specialist medical resources and objective diagnostic technologies may be limited. GLIA Diagnostics is developing a platform intended ultimately to extend objective biological assessment beyond elite sport.
The access gap in community sport
In professional sport, dedicated medical support and specialist assessment may be readily available. At school, community and amateur levels, access can be much more limited.
Millions of children and adults participate in community sport, creating a need for scalable approaches that can complement established concussion recognition, assessment and referral pathways.
GLIA is investigating how objective biological information could ultimately contribute to this environment alongside appropriate clinical assessment.
The scale of the challenge
Large participation base
Community and amateur sport involves large numbers of athletes across age groups and sporting codes.
Limited diagnostic access
Objective diagnostic technologies are generally less accessible outside elite and professional sport.
Variable medical support
Access to trained clinicians and specialist concussion services varies considerably across community sport.
Need for scalable tools
There is a need for practical assessment technologies that can complement established concussion pathways closer to the point of need.
The diagnostic gap
No doctor on the sideline
At community level, access to trained clinicians and advanced diagnostic technologies can be limited. Coaches, trainers and parents may therefore need to recognise a suspected concussion and escalate the athlete for appropriate assessment using established concussion protocols.
A validated blood-based biomarker test could potentially add objective biological information to this pathway, complementing symptom assessment and established concussion protocols rather than replacing clinical judgement.
The GLIA approach
Extending Objective Assessment
Designed for the field
GLIA NeuroTESTA is being developed as a portable point-of-care platform intended for use closer to where injury occurs. The intended system is designed to minimise dependence on conventional laboratory infrastructure while remaining complementary to appropriate clinical assessment.
Adding Objective Biology
GLIA is investigating whether its circulating miRNA panel can provide objective biological information following suspected concussion and across recovery. The intended role is complementary to clinical and observational assessment, not a replacement for it.
Accessible by design
Portability, workflow simplicity and accessibility are important development objectives for GLIA NeuroTESTA. The long-term aim is to make objective biological assessment more accessible beyond major hospitals and elite sporting environments.
A focus on younger athletes
Younger athletes represent an important population for concussion research and improved assessment. Any future use of GLIA technology in paediatric or youth sport would require appropriate clinical studies, validation and regulatory clearance.
Supporting Clearer Escalation Pathways
GLIA’s future platform is intended to provide accessible biological information closer to the point of need. It is not intended to enable coaches, trainers or parents to independently diagnose concussion or medically clear an athlete.
Building the evidence base
Future research in community sport could contribute to a broader understanding of concussion biology and recovery. Appropriate study design, clinical oversight and regulatory requirements would apply before any broader clinical deployment.
Point-of-care diagnostics
Developed for Near-Patient Use
GLIA NeuroTESTA is being developed as a rapid, portable PoC platform with a target sample-to-result time of approximately 20 minutes. Potential applications in sport remain subject to analytical validation, clinical studies and regulatory clearance.
About GLIA NeuroTESTA
Explore further
Related topics
Elite Sport
How GLIA Diagnostics applies to professional and high-performance sporting environments.
Learn more →
TBI Biomarkers
The molecular science behind objective TBI detection — beyond symptom checklists.
Learn more →
microRNA Science
Investigating circulating miRNA biology associated with TBI and recovery.
Learn more →
GLIA NeuroTESTA
A portable point-of-care platform under development for near-patient molecular assessment.
Learn more →
Advancing Objective Assessment Across Sport
GLIA Diagnostics is developing a platform intended to expand access to objective biological information across sporting environments. The technology remains investigational and is not yet approved for clinical diagnostic use.
Explore the science